High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: Comparison with non-cancerous lesions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: Comparison with non-cancerous lesions

Published:2011-03-17 Issue:5 Volume:61 Page:281-289
ISSN:1320-5463
Container-title:Pathology International
language:en
Short-container-title:

Author:

Ichinoe Masaaki,Mikami Tetuo,Yoshida Tsutomu,Igawa Ikuyo,Tsuruta Tomoko,Nakada Norihiro,Anzai Naohiko,Suzuki Yoshiyuki,Endou Hitoshi,Okayasu Isao

Publisher

Wiley

Subject

General Medicine,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1827.2011.02650.x/fullpdf

Reference19 articles.

1. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98);Kanai;J Biol Chem,1998

2. Cloning and expression of a b(0,+)-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT. A new candidate gene for cystinuria;Rajan;J Biol Chem,1999

3. L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer;Sakata;Pathol Int,2009

4. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma;Kobayashi;J Surg Oncol,2005

5. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma;Kaira;Lung Cancer,2009

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy;Molecular Metabolism;2024-06

2. ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion;Cell Death Discovery;2024-02-24

3. Exploring Amino Acid Transporters as Therapeutic Targets for Cancer: An Examination of Inhibitor Structures, Selectivity Issues, and Discovery Approaches;Pharmaceutics;2024-01-30

4. Small molecule, nanoparticle and liposomal strategies for LAT1-mediated chemotherapy delivery;Results in Chemistry;2023-12

5. Metabolic codependencies in the tumor microenvironment and gastric cancer: Difficulties and opportunities;Biomedicine & Pharmacotherapy;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3